CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.
-
(2016/02/21)
Chemokine receptor antagonists and methods of use thereof
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: formula (1) or physiologically acceptable salt thereof.
-
(2008/06/13)
More Articles about upstream products of 849106-19-0